Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 31 | 2023 | 151 | 7.750 |
Why?
|
| Lung | 15 | 2024 | 255 | 2.650 |
Why?
|
| Pulmonary Emphysema | 12 | 2021 | 22 | 2.520 |
Why?
|
| Osteoporosis | 8 | 2022 | 66 | 1.750 |
Why?
|
| Smoking | 15 | 2023 | 499 | 1.610 |
Why?
|
| Forced Expiratory Volume | 11 | 2023 | 97 | 1.130 |
Why?
|
| Tomography, X-Ray Computed | 15 | 2022 | 912 | 1.100 |
Why?
|
| Emphysema | 6 | 2021 | 12 | 1.080 |
Why?
|
| Humans | 56 | 2024 | 31836 | 0.850 |
Why?
|
| Bone Density | 7 | 2022 | 194 | 0.790 |
Why?
|
| Respiratory Function Tests | 12 | 2023 | 108 | 0.750 |
Why?
|
| Female | 38 | 2024 | 19859 | 0.690 |
Why?
|
| Quality of Life | 4 | 2023 | 924 | 0.680 |
Why?
|
| Male | 37 | 2024 | 19091 | 0.680 |
Why?
|
| Risk Factors | 16 | 2023 | 3851 | 0.640 |
Why?
|
| HIV Infections | 3 | 2021 | 394 | 0.610 |
Why?
|
| Aged | 25 | 2023 | 10288 | 0.610 |
Why?
|
| Middle Aged | 28 | 2023 | 11824 | 0.600 |
Why?
|
| Autoantibodies | 3 | 2020 | 49 | 0.590 |
Why?
|
| Coronary Artery Disease | 3 | 2023 | 398 | 0.570 |
Why?
|
| Brain Ischemia | 1 | 2018 | 145 | 0.560 |
Why?
|
| Phenotype | 5 | 2023 | 635 | 0.550 |
Why?
|
| Atherosclerosis | 3 | 2023 | 767 | 0.510 |
Why?
|
| Atrial Fibrillation | 2 | 2023 | 322 | 0.510 |
Why?
|
| Asthma | 2 | 2023 | 298 | 0.510 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 211 | 0.500 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 8 | 0.480 |
Why?
|
| Heat-Shock Proteins | 2 | 2020 | 34 | 0.470 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2024 | 30 | 0.470 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 480 | 0.470 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2013 | 7 | 0.450 |
Why?
|
| Cohort Studies | 13 | 2022 | 1824 | 0.440 |
Why?
|
| Stroke | 1 | 2018 | 581 | 0.430 |
Why?
|
| Health Literacy | 1 | 2023 | 29 | 0.430 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2023 | 54 | 0.430 |
Why?
|
| Cardiovascular System | 1 | 2023 | 43 | 0.420 |
Why?
|
| Sarcopenia | 1 | 2022 | 62 | 0.400 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2021 | 2 | 0.400 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 70 | 0.370 |
Why?
|
| Sp1 Transcription Factor | 1 | 2020 | 3 | 0.370 |
Why?
|
| F-Box Proteins | 1 | 2020 | 4 | 0.370 |
Why?
|
| Hip Fractures | 1 | 2020 | 30 | 0.360 |
Why?
|
| Spirometry | 3 | 2023 | 30 | 0.360 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1122 | 0.360 |
Why?
|
| Airway Obstruction | 3 | 2021 | 30 | 0.360 |
Why?
|
| Disease Progression | 5 | 2023 | 593 | 0.360 |
Why?
|
| Population Surveillance | 1 | 2021 | 125 | 0.350 |
Why?
|
| Muscle Development | 1 | 2020 | 49 | 0.350 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 89 | 0.340 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 105 | 0.330 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 114 | 0.330 |
Why?
|
| Pain | 1 | 2021 | 287 | 0.330 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 25 | 0.320 |
Why?
|
| Depression | 1 | 2021 | 442 | 0.300 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 513 | 0.300 |
Why?
|
| Comorbidity | 5 | 2021 | 566 | 0.290 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 47 | 0.290 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 899 | 0.290 |
Why?
|
| Models, Biological | 1 | 2019 | 391 | 0.280 |
Why?
|
| Pneumonectomy | 1 | 2016 | 6 | 0.270 |
Why?
|
| Adiposity | 1 | 2017 | 198 | 0.270 |
Why?
|
| Bronchoscopy | 1 | 2016 | 51 | 0.260 |
Why?
|
| Prospective Studies | 6 | 2022 | 2277 | 0.260 |
Why?
|
| Epidemiologic Methods | 1 | 2014 | 24 | 0.250 |
Why?
|
| Bacterial Capsules | 1 | 2024 | 5 | 0.240 |
Why?
|
| Klebsiella Infections | 1 | 2024 | 5 | 0.240 |
Why?
|
| Phagocytosis | 1 | 2024 | 15 | 0.240 |
Why?
|
| Klebsiella pneumoniae | 1 | 2024 | 10 | 0.240 |
Why?
|
| Complement System Proteins | 1 | 2024 | 10 | 0.240 |
Why?
|
| Adult | 13 | 2022 | 9327 | 0.240 |
Why?
|
| Interleukin-4 | 2 | 2013 | 22 | 0.240 |
Why?
|
| Prognosis | 5 | 2021 | 1498 | 0.230 |
Why?
|
| Software | 1 | 2014 | 127 | 0.230 |
Why?
|
| B-Cell Activating Factor | 1 | 2013 | 3 | 0.230 |
Why?
|
| Antigen-Antibody Complex | 1 | 2013 | 4 | 0.220 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 74 | 0.220 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 26 | 0.220 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 121 | 0.210 |
Why?
|
| Bone and Bones | 2 | 2014 | 91 | 0.200 |
Why?
|
| Collagen Type I | 2 | 2018 | 42 | 0.200 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2011 | 66 | 0.200 |
Why?
|
| Serum Amyloid P-Component | 1 | 2021 | 3 | 0.190 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1527 | 0.190 |
Why?
|
| Metformin | 1 | 2021 | 22 | 0.190 |
Why?
|
| Cell Differentiation | 1 | 2013 | 468 | 0.190 |
Why?
|
| Mice | 3 | 2024 | 2476 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2021 | 916 | 0.190 |
Why?
|
| Coronary Vessels | 1 | 2021 | 158 | 0.180 |
Why?
|
| United States | 5 | 2022 | 3925 | 0.170 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 2271 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 239 | 0.170 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 11 | 0.170 |
Why?
|
| Skin Aging | 1 | 2019 | 9 | 0.170 |
Why?
|
| Peptide Fragments | 1 | 2011 | 398 | 0.160 |
Why?
|
| Muscles | 2 | 2023 | 62 | 0.160 |
Why?
|
| Prevalence | 3 | 2019 | 979 | 0.160 |
Why?
|
| Inflammation | 2 | 2023 | 540 | 0.160 |
Why?
|
| Absorptiometry, Photon | 4 | 2021 | 137 | 0.150 |
Why?
|
| Pectoralis Muscles | 2 | 2021 | 5 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 155 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2023 | 3488 | 0.150 |
Why?
|
| Interleukin-13 | 1 | 2007 | 28 | 0.150 |
Why?
|
| Obesity | 1 | 2015 | 1158 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2023 | 3988 | 0.140 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 42 | 0.140 |
Why?
|
| Cytokines | 1 | 2007 | 259 | 0.130 |
Why?
|
| Linear Models | 2 | 2020 | 449 | 0.130 |
Why?
|
| Algorithms | 3 | 2019 | 495 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 155 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1424 | 0.120 |
Why?
|
| Animals | 3 | 2024 | 7450 | 0.120 |
Why?
|
| Spinal Fractures | 1 | 2015 | 43 | 0.120 |
Why?
|
| Respiratory Mucosa | 1 | 2024 | 13 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 12 | 0.120 |
Why?
|
| Acute Lung Injury | 1 | 2024 | 33 | 0.120 |
Why?
|
| ROC Curve | 1 | 2023 | 167 | 0.110 |
Why?
|
| Mass Screening | 2 | 2020 | 263 | 0.110 |
Why?
|
| Allergens | 1 | 2023 | 17 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2024 | 444 | 0.110 |
Why?
|
| Survival Rate | 2 | 2021 | 884 | 0.110 |
Why?
|
| Morbidity | 1 | 2022 | 99 | 0.100 |
Why?
|
| Hand Strength | 1 | 2022 | 100 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2021 | 1431 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 127 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 686 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 531 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 766 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 159 | 0.100 |
Why?
|
| Health Behavior | 1 | 2023 | 231 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 300 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 168 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 376 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 24 | 0.090 |
Why?
|
| Adolescent | 2 | 2023 | 3511 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 756 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1012 | 0.090 |
Why?
|
| Myoblasts, Skeletal | 1 | 2020 | 19 | 0.090 |
Why?
|
| Body Composition | 1 | 2021 | 388 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 283 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 208 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 771 | 0.080 |
Why?
|
| Systems Biology | 1 | 2019 | 10 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2023 | 632 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2020 | 189 | 0.080 |
Why?
|
| Vitamin D | 1 | 2020 | 183 | 0.080 |
Why?
|
| Kidney | 1 | 2012 | 515 | 0.080 |
Why?
|
| Time Factors | 1 | 2023 | 2146 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2020 | 833 | 0.080 |
Why?
|
| Research Design | 2 | 2014 | 310 | 0.070 |
Why?
|
| Sex Factors | 2 | 2015 | 662 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2019 | 197 | 0.070 |
Why?
|
| Exercise Tolerance | 1 | 2017 | 124 | 0.070 |
Why?
|
| Child | 1 | 2023 | 2425 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2012 | 293 | 0.060 |
Why?
|
| Pennsylvania | 1 | 2015 | 83 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2014 | 128 | 0.060 |
Why?
|
| Computational Biology | 1 | 2014 | 91 | 0.060 |
Why?
|
| Bacteremia | 1 | 2024 | 58 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 79 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2014 | 220 | 0.060 |
Why?
|
| Leptin | 1 | 2023 | 71 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2013 | 27 | 0.060 |
Why?
|
| Focus Groups | 1 | 2023 | 114 | 0.060 |
Why?
|
| Genomics | 1 | 2023 | 84 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2013 | 184 | 0.050 |
Why?
|
| Dyspnea | 1 | 2022 | 32 | 0.050 |
Why?
|
| Health Personnel | 1 | 2023 | 122 | 0.050 |
Why?
|
| Social Support | 1 | 2023 | 180 | 0.050 |
Why?
|
| Mutation | 1 | 2024 | 487 | 0.050 |
Why?
|
| Airway Remodeling | 1 | 2021 | 5 | 0.050 |
Why?
|
| Plethysmography | 1 | 2021 | 15 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 764 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 51 | 0.050 |
Why?
|
| Organ Size | 1 | 2021 | 208 | 0.050 |
Why?
|
| Procollagen | 1 | 2010 | 7 | 0.050 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 25 | 0.050 |
Why?
|
| Young Adult | 2 | 2022 | 2603 | 0.050 |
Why?
|
| Incidence | 2 | 2015 | 1192 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 334 | 0.040 |
Why?
|
| Elasticity | 1 | 2019 | 36 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 135 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 201 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2008 | 44 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2007 | 18 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2016 | 69 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 404 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 470 | 0.030 |
Why?
|
| Antibodies | 1 | 2014 | 52 | 0.030 |
Why?
|
| Demography | 1 | 2014 | 110 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 57 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 3294 | 0.030 |
Why?
|
| Macrophages | 1 | 2014 | 192 | 0.030 |
Why?
|
| Education | 1 | 2012 | 39 | 0.030 |
Why?
|
| Creatinine | 1 | 2012 | 195 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 105 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 305 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 22 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 298 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 895 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 461 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 777 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 874 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1187 | 0.020 |
Why?
|